Skip to content

News Category: Health & Medical

AAHRPP Accredits Five More Research Organizations, Including First in Japan

By asianet

The Association for the Accreditation ( https://c212.net/c/link/?t=0&l=en&o=3657696-1&h=2135994626&u=https%3A%2F%2Fwww.aahrpp.org%2F&a=Accreditation ) of Human Research Protection Programs has accredited five more research organizations, including its first organization in Japan, two public research universities, a children’s hospital and an acute-care hospital. Logo – https://mma.prnewswire.com/media/224365/aahrpp_logo.jpg At its September meeting, AAHRPP’s Council on Accreditation awarded full accreditation to: — Adventist Health Glendale, … Continued

Ivory Dentin Graft(TM), the First and Only Dentin Graft, Receives CE Mark

By asianet

– Ivory Dentin Graft creates a new dentin category of graft substitutes for repair and augmentation of bone defects. Developed by Ivory Graft Ltd.[]https://ivorygraft.com/, the Ivory Dentin Graft(TM) is a new dentin graft. This graft material has been tailored for use in dental procedures based on the advantages of autologous dentin grafts, documented and proven … Continued

The 6th China Health and Senior Care Conference held in southwest Chinese city Shizhu

By asianet

On August 30th, the 6th China Health and Senior Care Conference was held in Huangshui Town, a summer resort in Shizhu Tujia Autonomous County, southwest China’s Chongqing Municipality. Hosted by the Revolutionary Committee of the Chinese Kuomintang and the Chongqing Municipal Political Consultative Conference, the conference sought to promote the development of health care industry … Continued

Mediaseek’s Proprietary Neurofeedback Engine “Alpha Switch” and Its Smartphone Application Mentioned in International Journal

By asianet

– Engine and App Used in Research Paper on Chronic Low Back Pain Treatment at Pain Center of Chiba University Hospital Published in “Scientific Reports” – Mediaseek, Inc. (hereinafter referred to as “Mediaseek”) based in Tokyo is pleased to announce that a research article on the treatment of nonspecific chronic low back pain, conducted by … Continued

Smith+Nephew launches OR3O(TM) Dual Mobility System in Japan for use in primary and revision hip arthroplasty

By asianet

— Features proprietary OXINIUM(TM) DH material; eliminates Cobalt Chrome alloy reducing wear and corrosion risks [1] Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its OR3O Dual Mobility System for use in primary and revision hip arthroplasty in Japan. Compared with traditional solutions, dual mobility implants have a small diameter … Continued

Bugworks Research Inc. and Cytecare Cancer Hospitals announce collaboration to accelerate the development of cutting-edge Immuno-oncology therapies

By asianet

– Bugworks – a US, India and Australia based start-up with globally recognized expertise in drug discovery, has set up a dedicated Immuno-oncology ex vivo research lab at the Bengaluru-based hospital, Cytecare. – The lab bridges the translation from discovery to development, addressing several hard-to-treat cancers such as gastric, colorectal, renal cell, breast, head and … Continued

MagicTouch SCB receives IDE approval for In-Stent Restenosis indication

By asianet

The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch [ https://www.conceptmedical.com/product/magic-touch/ ] Sirolimus Coated Balloon (SCB) indicated for In-Stent Restenosis (ISR). US FDA’s IDE approval allows the MagicTouch SCB [ https://www.conceptmedical.com/product/magic-touch/ ] to be used in a pivotal clinical study to support safety and effectiveness of this combination product. The data … Continued

Nippon Express Obtains GDP Certification of Compliance with WHO Standards at East Japan Pharmaceutical Center

By asianet

– Dedicated Pharmaceutical Logistics Facility Offers Storage and Transport in Two Temperature Ranges – Nippon Express Co., Ltd. (hereafter “Nippon Express”), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired Good Distribution Practice (GDP) certification for its East Japan Pharmaceutical Center (Kuki City, Saitama Prefecture), effective July 29, evidencing its compliance with WHO standards … Continued

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

By asianet

Concept Medical (https://www.conceptmedical.com/) announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch (https://www.conceptmedical.com/product/magic-touch/) Sirolimus Coated Balloon). The Randomized Controlled Trial (RCT) was conceptualized with the aim of understanding how the treatment indications and applications of Drug Coated Balloon (DCB) in coronary artery disease (CAD) can … Continued

Turn Biotechnologies launches eTurna(TM) delivery platform designed specifically to enable nucleic acid therapeutics

By asianet

— The proprietary platform is versatile, equally effective with different cargoes, routes of administration Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced it has created a novel platform to safely and effectively deliver nucleic acid therapeutics – a major expansion of the company’s business. The eTurna … Continued